Skip to main content

Two Maryland biotechs get $36 million to aid in new vaccine development

The project will be funded by Norway's Coalition for Epidemic Preparedness Innovations, which aims to develop vaccines to stop future epidemics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.